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DNA has been widely used as a key tether to promote self-organization of super-assemblies with emer-
gent properties. However, control of this process is still challenging for compartment assemblies and to
date the resulting assemblies have unstable membranes precluding in vitro and in vivo testing. Here we
present our approach to overcome these limitations, by manipulating molecular factors such as compart-
ment membrane composition and DNA surface density, thereby controlling the size and stability of the
resulting DNA-linked compartment clusters. The soft, flexible character of the polymer membrane and
low number of ssDNA remaining exposed after cluster formation determine the interaction of these clus-
ters with the cell surface. These clusters exhibit in vivo stability and lack of toxicity in a zebrafish model.
To display the breadth of therapeutic applications attainable with our system, we encapsulated the medi-
cally established enzyme laccase within the inner compartment and demonstrated its activity within the
clustered compartments. Most importantly, these clusters can interact selectively with different cell lines,
opening a new strategy to modify and expand cellular functions by attaching such pre-organized soft
DNA-mediated compartment clusters on cell surfaces for cell engineering or therapeutic applications.
1. Introduction
The unique features of DNA enable the organization of nano-
structures into larger superstructures and macroscopic super-
lattices with well-defined orientations depending on their
intrinsic architecture.1,2 Current knowledge and experiences
with DNA-organized supramolecular structures revolve around
exploiting DNA-linked rigid nanostructures,3,4 for example
gold nanoparticles.5,6 The rigidity of particles imparts direc-
tionality to hybridization interactions and the high-density of
DNA strands on the surfaces act as ‘valencies’ to manipulate
the stereo-organization precisely, either when DNA chains or
DNA origami direct the organization,7–9 or when steric hin-
drance induces formation of core-satellite structures.5,7,10,11
A completely different framework of interactions is induced
when the nanostructure is deformable, and molecules can lat-
erally diffuse inside the assembly, causing a constant fluctu-
ation in exposed molecular groups bearing the DNA. Thus, the
unique properties of the resulting organization open up a new
field of soft DNA-linked compartment assemblies. Only
recently have soft nanocompartments, especially liposomes
and polymersomes, been exploited for DNA-mediated
organization12,13 due to the preconception that their inherent
flexibility interferes with the creation of defined structures,14
such as superlattices assembled by rigid nanoparticles. For
example, in the case of liposomes, DNA-mediated assembly
led to their precipitation from solution or membrane fusion
due to their low stability.13,15,16 In the case of polymersome
based sub-micrometer sized assemblies, only one example has
been reported12 with no in vitro or in vivo testing, thus insights
into the behavior of such soft materials in a biological environ-
ment are still lacking. Nevertheless, nanocompartments have
unique advantages due to their intrinsic architecture, hollow
spheres with hydrophilic cavities surrounded by a membra-
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nous structure possessing hydrophobic cores. They enable the
efficient loading of various hydrophilic and hydrophobic thera-
peutic agents ranging from small molecular weight drugs to
DNA and RNA for drug delivery,17–21 nanoparticles for catalytic
properties,22,23 and various enzymes for the development of
artificial organelles24 functional in vivo.25 While both lipo-
somes and polymersomes allow tailoring for biocompatibility,
stimuli-responsiveness and biodegradability, polymersomes
are an improved alternative as they exhibit higher mechanical
stability compared to their counterpart, liposomes.24,26–28
There are several examples of sub-micrometer sized nano-
particle assemblies, however, only a few were proposed for cel-
lular interactions and phototherapies.5,10,29,30 The biological
application of such nanoparticle assemblies remains challen-
ging with most focusing on DNA intercalating molecules
loaded non-covalently in the hybridized DNA strands for their
delivery.5,30,31 Furthermore such nanoparticle assemblies
undergo fast disassembly in vitro and in vivo,10,30 implemented
as a strategy for clearance.10
Here, we present soft DNA-linked polymersome clusters as
a new type of compartment-assembly able to support efficient
bio-applications with the unique advantage of simultaneously
allowing the encapsulation of catalytic compounds and their
localization at desired locations controlled by their interaction
with cells. DNA-linked polymersomes represent a complemen-
tary platform to DNA–nanoparticle systems with a hierarchic
self-organization that has been manipulated by fine-tuning the
polymer membrane composition, the surface density of ssDNA
and polymersome concentration (Scheme 1). As the soft poly-
mersome clusters differ greatly with respect to other DNA-
mediated assemblies, we methodically probe their behavior
in vitro and in vivo to determine their suitability for future
applications. We present how such soft DNA-mediated com-
partment assemblies interact with different cell lines resulting
in binding selectivity towards epithelial cells via scavenger
receptors. Notably, for the first time the realization of cellular
membrane attachment of DNA-linked super-assemblies is
achieved. These clusters are non-toxic and their characteristic
behavior is also maintained in vivo. Attachment of such clus-
ters to the cell surface could prove momentous, as it would
provide a universal and innocuous approach for non-genetic
therapeutic cell engineering32,33 but also detoxification of
xenotoxins by encapsulating enzymes within the inner com-
partment. Following along this line, we encapsulated laccase
as an extensively studied enzyme with multiple
applications34,35 within the clustered polymersomes and
demonstrated the catalytic potential of the clusters to prevent
internalization of harmful compounds inducing apoptosis. In
contrast to rigid DNA-linked nanoparticles and assemblies
that offer limited bioactivity after endocytosis, we reveal that
both the deformability of the polymersome’s membrane and
the lateral diffusion of the polymer chains within the mem-
brane contribute to their surprising stability and determine
the clusters’ destiny in biologically relevant environments. The
multiple compartments with both aqueous cavities and hydro-
phobic boundaries benefit the integration of active bio-
molecules with diverse chemical properties into one nanoplat-
form, providing combined and synchronized therapeutic and
diagnostic solutions. All these features make them truly
unique soft compartment assemblies with high potential for
bio-applications, such as regenerative medicine or cell engin-
eering to restore, replace or integrate new cellular functions.
2. Results and discussion
2.1. Assembly of ssDNA functionalized polymersomes and
DNA-linked polymersome clusters
In order to construct stable sub-micrometer sized polymer-
some clusters in a controllable manner, we carefully con-
sidered three key molecular factors: (i) the chemical nature
and morphology of the polymersomes’ membrane, (ii) the
DNA density and distribution on the polymersomes’ surface,
and (iii) the concentration of polymersomes.12 For polymer-
some formation, we selected the diblock copolymer poly(di-
methylsiloxane)-block-poly(2-methyloxazoline) (PDMS-PMOXA)
because of its low toxicity and biocompatibility.36,37 As pre-
viously shown, the combination of PMOXA-PDMS-PMOXA tri-
block copolymer with azide-functionalized diblock
PDMS-PMOXA copolymer, bearing a longer PMOXA block,
forms polymersomes with exposed azide functional groups on
the polymersomes’ surface.12 We then linked dibenzocyclo-
octyne (DBCO)-functionalized ssDNA (DBCO-ssDNA) to the
polymersomes and promoted their zipping by DNA hybridiz-
ation.12 Here we changed the approach and synthesized only
diblock copolymers, PDMS62-PMOXA13 and PDMS71-PMOXA25-
OEG3-N3, with similar PDMS block lengths aimed at circum-
venting hydrophobic mismatch and phase separation between
the two polymers, consequently favoring formation of polymer-
somes (Fig. 1A, Fig. S1, and Table S1†). Switching to this new
Scheme 1 Synthetic nanocompartments (polymersomes, shown in
blue and magenta) assembled from amphiphilic diblock copolymers
(right insert depicting the polymeric membrane) are interconnected
using DNA hybridization as the driving force for their self-organization
into clusters (left insert highlighting the hybridized DNA that locks in
place the polymersomes). Such soft flexible assemblies selectively inter-
act with the scavenger receptors on the cell membranes in vitro and
in vivo leading to attachment to the cell surface.
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block copolymer combination facilitated an increase in
PDMS71-PMOXA25-OEG3-N3 content to 20 mol% without per-
turbing the self-assembly (Fig. S2†), thus obtaining polymer-
somes with average apparent hydrodynamic diameter (DH) of
190 ± 30 nm (s.e.m, n = 3) as obtained by dynamic light scatter-
ing (DLS, Fig. S4 and Table S2†).
As mentioned above, key molecular factors that affect the
process of hierarchic self-organization of polymersomes into
clusters are both the number of ssDNAs per polymersome
and concentration of ssDNA–polymersomes. To modulate the
apparent DH of DNA-linked polymersome clusters, we kept
the concentration of complementary ssDNA–polymersomes
constant (0.2 mg mL−1) and varied only the number of
ssDNAs per polymersome. We linked DBCO-ssDNAs onto the
polymersomes’ surface by strain-promoted azide–alkyne
cycloaddition (SPAAC) reaction between DBCO-ssDNAs and
polymersomes with exposed N3 groups. By varying the N3
content per polymersome, we varied the number of ssDNAs
per polymersome from 1 ± 1 to 289 ± 72, as measured by fluo-
rescence correlation spectroscopy (FCS, Fig. S3, see ESI† for
details). The perikinetic clustering (solely driven by diffusion)
of complementary ssDNA–polymersomes, at equal mass
ratios and 37 °C, was investigated by monitoring the change
in apparent DH over time (Fig. 1B and C). The hybridization
of complementary ssDNA on the polymersome surface
resulted in a rapid increase in the apparent DH until reaching
a plateau with a defined range, where controlled cluster for-
mation occurs. Self-organization into sub-micrometer sized
clusters takes place only for complementary ssDNA–polymer-
somes with a number of linked ssDNAa/b ranging from
34 ± 33 to 188 ± 58 and 8 ± 5 to 111 ± 29 (Fig. S3 and S4†),
corresponding to 1 to 20 mol% of azide-functionalized
diblock content, respectively (Fig. 1E and F). Lowering the
amount of linked ssDNA per polymersome does not sustain
cluster formation, while a higher number of ssDNA per poly-
mersome resulted in uncontrollable aggregation, as observed
by the instantaneous formation of large clusters with an
apparent DH > 1 µm.
Fig. 1 Principles and preparation of DNA-linked polymersome clusters. (A) Schematic representation of assembled ssDNA–polymersomes, chemi-
cal structures of the two block copolymers used and the sequence of the two complementary ssDNAs. (B) Schematic representation of the cluster
assembly process where the polymersomes first link together via DNA hybridization, followed by migration of non-hybridized ssDNAs and sub-
sequent hybridization to form a DNA bridge area in between the polymersomes. (C) Self-organization of ssDNA–polymersomes into clusters
reported as the change in their apparent DH as a function of time for 0.5 mol% (orange and light orange), 1 mol% (magenta and light magenta),
5 mol% (red and light red), 10 mol% (green and light green) and 20 mol% (blue and light blue) azide-functionalized diblock copolymers. The results
represent two independent measurements shown on the graph as hues of the same color. (D) The distribution of the average apparent DH of:
ssDNAa-polymersomes (200 nm ± 30 nm, s.e.m, n = 3,) comprised of 20 mol% azide-functionalized diblock copolymers (blue) and of the corres-
ponding DNA-linked polymersome clusters (440 nm ± 100 nm, s.e.m, n = 3) (red). (E–F) Transmission electron microscopy (TEM) and cryo-TEM
micrographs of the DNA-linked polymersome clusters P20-ab. Scale bars are 500 nm (E) and 100 nm (F).
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Ultimately, we obtained a series of polymersome clusters
with a size distribution corresponding to a lognormal distri-
bution function (statistical analysis, ESI†) and an average
apparent DH from 280 ± 80 nm to 440 ± 100 nm (s.e.m., n = 3,
Fig. 1D and Fig. S4†). The distribution of the number of poly-
mersomes/cluster for polymersomes with 1 to 20 mol% azide-
functionalized diblock content was fitted with a log-normal
distribution function as well (statistical analysis, ESI†). The
clusters are composed on average of 2.5 ± 1.3 to 3.4 ± 1.6 poly-
mersomes per cluster with a non-bound polymersome fraction
lower than 5%, determined from transmission electron
microscopy (TEM, Fig. S4†). In contrast with ssDNA-coupled
rigid nanoparticles, ssDNA–polymersomes are advantageous
when forming sub-micrometer sized clusters in a controllable
manner as the ssDNA-bearing block copolymers migrate
through the membrane and are then locked in a bridging area
between linked polymersomes (Fig. 1B and F).12,38 The for-
mation of this three-dimensional bridging area with an area
regulated by the number of dsDNAs holding the polymersomes
together and opening dependent on the length of dsDNA,
rather than a ‘spot’, functions as a barrier thus sheltering the
dsDNA from exposure to the environment. The migration of
ssDNA to the bridging area also decreases the ssDNA density
in the non-bridging area and eventually terminates the cluster-
ing process. Therefore, the formation of sub-micrometer sized
clusters is kinetically controlled by using mechanically stable
polymersomes with a relatively low ssDNA density on the
surface to prevent aggregation or rupture.
To further probe the stability of the bridging region, we
incubated the clusters in presence of DNase I, the most preva-
lent endonuclease in serum (Fig. S5†). We observed that poly-
mersome clusters with an apparent DH above 300 nm remain
clustered in presence of 1 µg mL−1 of DNase I. However, no
clusters were formed when the ssDNA–polymersomes were
pre-treated with 1 µg mL−1 of DNase I, suggesting the DNA
strands on single ssDNA–polymersomes have been digested.
Narrowing the bridging area between polymersomes from 7.1
± 0.5 nm to 3.5 ± 0.3 nm by reducing the length of the ssDNA
from 22 bp to 11 bp effectively protects the polymersome clus-
ters against DNase I hydrolysis (Fig. S5†). The clusters linked
by 22 bp DNA disassembled to single polymersomes at a
DNase I concentration of 10 µg mL−1, while clusters linked by
11 bp DNA preserved their clustered structures.
2.2. Examination of DNA-linked polymersome clusters’
behavior in vitro
As the polymersome clusters we designed differ greatly with
respect to other DNA-mediated assemblies, and no other soft
compartment assemblies were studied in vitro, it was funda-
mental to study their interactions in vitro and determine their
potential for biomedical applications. Under physiological
conditions, e.g. in cell medium, the colloidal stability of DNA
functionalized materials might be affected due to interactions
between proteins and the DNA.39 Thus, we first examined the
stability of the 22 bp ssDNA–polymersome clusters in cell
medium (Fig. S6A†). The clusters remained stable up to
10 hours due to the strong interactions between complemen-
tary ssDNAs located in the sheltered bridging region
(Fig. S6A†).
Prior to determining if there are selective interactions
between the clusters and epithelial cells, we evaluated the tox-
icity of the ssDNA polymersomes and DNA-linked clusters
using an MTS assay (Fig. S6E†). No toxicity was obtained up to
40 µg mL−1. Subsequently, we examined their interactions
with three cell lines, i.e. HeLa, HEK293T and U87-MG, to deter-
mine if the DNA-linked polymersome clusters are stable, inter-
nalized or have any inherent selectivity towards a specific cell
line. We incubated cells in the presence of low concentrations
(13 µg mL−1) of unmodified polymersomes, ssDNA–polymer-
somes, 400 nm sized small clusters and 1000 nm large clusters
(see Methods for the preparation of large clusters). In polymer-
somes functionalized with 22 bp ssDNAa we encapsulated a
fluorescent dye DY-633 (DY-633-P20-a) and in polymersomes
functionalized with the complementary 22 bp ssDNAb ATTO
488 dye (ATTO-488-P20-b) as small molecule mimics and for
visualization via confocal laser scanning microscopy (CLSM,
Fig. S6C and D†). After 24 h, we thoroughly washed the cells to
remove unbound polymersomes or clusters and stained the
cellular membrane using the CellMask™ orange plasma mem-
brane stain, prior to imaging. DY-633-P20-a as well as both
small and large polymersome clusters accumulated on the cell
surface predominantly at cell junctions of HEK293T and HeLa
cells (Fig. 2A, Fig. S7A–C† for transmission channels, Fig. S8A–
J and S9A–C† for repeat experiments). Using flow cytometry,
we confirmed the presence of clusters, most likely still
attached to the cell surface; however, the precise location
cannot be determined using this technique (Fig. S10A and B†).
Unmodified polymersomes showed no binding and were not
internalized (Fig. S8B and G†). Furthermore, the binding inter-
action between the clusters with the cell membrane appears to
be more favorable than the one between single ssDNA–poly-
mersomes and cells, since rigorous washing steps prior to
imaging did not result in detachment and there appear to be
more clusters than single ssDNA–polymersomes retained on
the cell membrane as shown by the fluorescence intensity
(Fig. 2). A local accumulation of clusters on the cell surface is
key feature that will allow their future application for bio-
medical applications. In addition, polymersome clusters have
the advantages, opposed to non-clustered or ssDNA–polymer-
somes to provide segregated spaces at the nanoscale support-
ing simultaneous functionality of separate compounds and
simultaneous co-localization of such comportments to
improve their overall efficiency. As observed in the merged
image, DY-633-P20-a overlaps with ATTO-488-P20-b, to a larger
extent as compared to the control polymersomes bearing non-
complementary ssDNA (Fig. 2B), indicating that the clusters
are intact and did not dissociate over the 24 h incubation
period. The large 1000 nm clusters appear to form a network
like structure that expands to cover large portions of the cell
outer membrane (Fig. 2C) suggesting an active rearrangement
of the clusters in vitro. Binding and accumulation of the clus-
ters to the cell surface occurred within the first hour of incu-
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Fig. 2 Interaction of DNA-linked polymersome clusters with HEK293T and U87-MG cells. (A) CLSM micrographs showing attachment to surface of
HEK293T cells of ssDNA polymersomes loaded with DY-633 (DY-633-P20-a, magenta), 400 nm small clusters and 1000 nm large clusters composed
of ssDNAa-polymersomes loaded with DY-633 (DY-633-P20-a magenta) and ssDNAb-polymersomes loaded with ATTO 488 (ATTO-488-P20-b,
cyan). Scale bar = 10 µm. (B) 3D z-stack reconstruction showing 400 nm clusters on the cell surface (left) and non-complementary ssDNA–polymer-
somes (right). Scale bar = 20 µm. (C) Z-Stack of large polymersome clusters forming a network on the surface of HEK293T cells. Scale bar = 20 µm.
(D) CLSM micrographs showing uptake in U87-MG cells of ssDNA polymersomes loaded with DY-633 (DY-633-P20-a, magenta), 400 nm small clus-
ters and 1000 nm large clusters composed of ssDNAa-polymersomes loaded with DY-633 (DY-633-P20-a, magenta) and ssDNAb-polymersomes
loaded with ATTO 488 (ATTO-488-P20-b, cyan). Scale bar = 10 µm. The experiments were performed in cell media containing 10% fetal calf serum.
The cell membrane was stained using CellMaskTM orange plasma membrane stain prior to imaging.
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bation with no precipitation or accumulation visible in regions
where the cells were not present, thus further demonstrating
the high affinity of the clusters towards the cell surface
(Fig. S11†). Binding to the cell surface is unique as most
reported DNA coupled nanostructures and assemblies are
internalized within cells and do not form networks on the
surface.5,10,29,30 This behavior is again an exceptional emer-
ging property of using soft DNA-linked polymersomes bearing
a low DNA surface density. This leads to a low adhesion energy
for full wrapping of cells through receptor binding and thus
might not be sufficient to activate endocytosis.40 A second
factor contributing to this unique behavior is that ssDNA–poly-
mersomes and the DNA-linked polymersome clusters are
much larger and more deformable compared to rigid gold
nanoparticles where the stiffness of the surface promotes cell
membrane engulfment.41 In stark contrast, our clusters spread
along the cell membrane without significant membrane defor-
mation, thereby limiting the internalization processes.
Next, we examined the interaction of unmodified polymer-
somes, ssDNA–polymersomes and the small and large clusters
with U87-MG glioblastoma cells, known to have a higher endo-
cytotic potential and favor uptake of larger sized particles.42,43
Interestingly, we observed limited internalization of both the
400 nm clusters and to a lesser extent of the larger clusters
(Fig. 2D, Fig. S7D–F, S8K–P and S9D–E†). DY-633-P20-a and
ATTO-488-P20-b polymersomes from within the cluster coloca-
lize, as seen also from the individual CLSM z-stack slices
(Fig. S8P†) indicating that the clusters preserve their integrity
following uptake, as re-clustering within the cell is improbable
(Fig. 2D). In the case of ssDNA–polymersomes and unmodified
polymersomes it was difficult to determine the extent of
uptake or attachment by CLSM due to their scarcity; however,
analysis of the flow cytometry data suggests that both were
internalized or in the case of ssDNA possibly attached to the
cell surface (Fig. S10C†). As mentioned above, the precise
location cannot be determined via flow cytometry, however
unmodified polymersomes cannot attach to the cell surface
and have been shown to be readily uptaken by cells.25,44 The
observed uptake via CLSM of the small and large clusters is in
agreement with the fact that U87-MG cell line preferentially
uptakes larger particles (Fig. S10C†).42,43
2.3. Mechanism of DNA-linked polymersome cluster
attachment to cells
To better understand the in vitro behavior and specific cellular
interaction of the polymersome clusters, we explored the
binding mechanism of the ssDNA–polymersomes and clusters
with HEK293T cells, as model cell line. Patel et al. showed that
DNA-functionalized nanoparticles are internalized via binding
to scavenger receptors.45 To test whether our DNA-polymer-
some clusters also bind to this class of receptors, we per-
formed competitive inhibition experiments. We preincubated
the cells with increasing concentrations of two scavenger
receptor ligands (i.e. polyinosinic acid (PolyI) and Fucoidan)
for 1 hour prior to addition of ssDNA–polymersomes, small
(400 nm) and large (1000 nm) clusters. As the concentration of
the inhibitors increases, surface binding of the ssDNA–poly-
mersomes, both small and large clusters, decreased in a dose
responsive fashion as compared to controls (Fig. 3A, B depict-
ing trend of large clusters and Fig. S12† transmission channel,
Fig. S13† for complete analysis). At the highest concentration
of PolyI, binding of the clusters was almost fully inhibited and
Fig. 3 Effect of scavenger receptor inhibitors on cluster cellular interaction. (A) CLSM micrographs of 1000 nm large DNA-linked polymersome
clusters composed of ssDNAa-polymersomes loaded with DY-633 (DY-633-P20a, magenta) and ssDNAb-polymersomes loaded with ATTO-488
(ATTO-488-P20b, cyan) in presence of increasing concentration of PolyI, a scavenger receptor inhibitor (0 to 50 µg mL−1, final concentration).
Addition of PolyI completely inhibits cell binding of the DNA-linked polymersome clusters even at the lowest concentration tested. (B) CLSM micro-
graphs of the 1000 nm large DNA-linked polymersome clusters in presence of increasing concentration of Fucoidan, a scavenger receptor inhibitor
(0 to 50 µg mL−1, final concentration). Scale bar 10 µm.
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to a lesser extent in the case of the Fucoidan inhibitor. These
results indicate that specific binding to epithelial cells is
indeed mediated through attachment of negatively charged
polymersome clusters to scavenger receptors. Of note,
although DNA migration occurs during the polymersome clus-
tering, approximately 50% of ssDNA on the polymersomes’
surface remains non-hybridized. The percentage of non-hybri-
dized ssDNA was determined by fluorescent resonance energy
transfer analysis (FRET, Fig. S6B†). Excess amount of ssDNAa-
Cy3 and polymersomes linked with ssDNAa-Cy3 (P20-b-Cy3)
were incubated with polymersomes linked with ssDNAb-Cy5
(P20-b-Cy5), respectively. The percentage of hybridized ssDNA,
when forming clusters, was calculated by dividing the fluo-
rescence intensity of P20-b-Cy5 hybridized with P20-b-Cy3 by
the value when P20-b-Cy5 is hybridized with an excess amount
of ssDNAa-Cy3. 50% of non-hybridized ssDNA on the polymer-
somes’ surface is also indicated by the increase in ζ-potential
from −11.00 ± 0.04 mV for DY-633-P20-a and −10.60 ± 0.02 mV
for ATTO-488-P20-b to −5.47 ± 0.02 mV for the clusters (s.e.m.,
n = 3, Table S4†). Therefore, the non-hybridized ssDNA on the
clusters contributes to their cellular interactions.
2.4. Development of catalytically active DNA-linked
polymersome clusters
Capitalizing on the fact that our clusters stably attach to the
cell surface, we subsequently focused on developing the clus-
ters for potential detoxification applications in the blood circu-
lation. Polymersome clusters attached to the cell surface of
blood vessels and loaded with catalytically active enzymes can
be applied as exogenous tool kits that simultaneously protect
the encapsulated cargo from degradation or deactivation and
can be used for the elimination of circulating toxic chemicals.
One solution we envision resides in taking a true and tested
enzyme, fungal laccase, and encapsulate it within the polymer-
somes. Laccases have been extensively used for bioremediation
applications, as they are known to act on multiple xenotoxic
compounds, such as pesticides and insecticides,34 anti-inflam-
matory drugs with a high incidence of misuse and overdose,
as for example Acetaminophen and aspirin,46 phenolic
compounds,47,48 polychlorinated biphenyls (PCBs) and poly-
cyclic aromatic hydrocarbons (PAH).49 While actions to reduce
the exposure to such toxins have been taken, microplastics,
ubiquitously present in the environment are now making their
way up the food chain and represent a new source of concern
as they leach out PCBs, phenolic substances and various other
endocrine disrupting compounds.50 Phenolic substances are
main chemical pollutants in soil and water and their pro-
duction is tremendous: for example, the annual output of
biphenyl A alone is up to 4.69 million tons.51 Luckily laccases
can also degrade such substrates relieving the toxic burden.52
Here as a proof of concept we encapsulate laccase in poly-
mersomes permeabilized by inserting the outer membrane
protein F (OmpF) into the membrane. We confirm that upon
encapsulation, either in single, unmodified polymersomes
(Lac-Polymersomes) or in DNA-clustered Lac-Polymersomes,
laccase maintains its activity and converts the substrate
Amplex Ultra Red to the fluorescent product resorufin (Fig. 4).
At the same concentration, both unmodified and clustered
Lac-Polymersomes show 40% of the activity of free enzymes,
whereas almost no activity can be detected from control Lac-
Polymersomes with no OmpF because their membrane is not
permeable for small molecules. In human serum, the DNA-
clustered Lac-Polymersomes truly exhibit their advantages, dis-
playing an increase in activity up to 80% of the activity of free
laccase in the same medium (Fig. 4). Previously, we have
shown that encapsulation not only helps maintain enzymatic
activity in complex medium, but also increases the stability of
the enzymes and protects them from degradation.44 In serum,
Fig. 4 Catalytic activity of DNA-polymersome clusters containing laccase. (A) Schematic representation of DNA-linked polymersome cluster with
catalytic activity by encapsulation of laccase (Lac) and permeabilization of the polymer membrane by insertion of OmpF. The encapsulated enzyme
laccase converts in situ Amplex Ultra Red to the fluorescent product resorufin. (B) Reaction efficiency of the free laccase, non-ssDNA modified poly-
mersomes containing encapsulated laccase (Naked Lac-Polymersomes), DNA-clustered Lac-Polymersomes equipped with OmpF, and control Lac-
Polymersomes that are not permeabilized (without OmpF). Reaction efficiency was determined by measuring the production of resorufin (Ex. λ =
529 nm, Em. λ = 600 nm; n = 3) both in PBS (orange) and in human serum (green).
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Fig. 5 Biodistribution and stability of DNA-linked polymersome clusters in vivo. (A) Schematic representation of anatomical regions in the zebrafish
model (DLAV = dorsal longitudinal anastomotic vessel, DA = dorsal aorta, PCV = posterior cardinal vein lined with scavenger receptors). Non-coup-
ling ssDNA polymersomes (SRB-P20-a and Dy-633-P20-a), small clusters and large clusters were injected into transgenic zebrafish embryos. CLSM
micrographs from the tail region were taken at specific time points after intravenous injection. Auto-fluorescence of pigment cells (bright red spots)
are visible in the dorsal region. (B) Time-dependent analysis of biodistribution of non-coupling ssDNA polymersomes or preformed DNA-linked
polymersome clusters (small clusters – 300 nm and big clusters – 500 nm) at 0.5, 4 and 24 hours (left). Scale bars = 50 µm. Schematic presentation
and biodistribution analysis of non-coupling polymersomes, small clusters and large clusters in PCV. Representative high magnification images are
shown (right). Scale bar = 10 µm. (C) Colocalization analysis of DY-633-P20-a and SRB-P20-b modified polymersomes, small clusters (average size
300 nm) and larger clusters (average size 500 nm) in vivo based on Manders’ M1 colocalization coefficient. Statistical analysis was performed by
one-way ANOVAwith a Bonferroni post hoc test. * p < 0.05 vs. non-coupling polymersomes at the same time point (means ± s.e.m., n = 3).
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free laccases were partially degraded while the ones inside the
polymersomes and clusters were protected. However, in serum
trace amounts of heme-containing proteins lead to further oxi-
dation of Amplex Ultra Red, causing a higher background than
observed in PBS. Nevertheless, by combining the robust DNA-
cluster system that attaches to the cell surface with the catalytic
capability of these clusters, we can utilize our system as extra-
cellular detoxification patches. In addition, the clusters
provide a better spatial localization than single-polymersomes,
especially supported by their specific interactions with the
cells. With future optimization, our enzyme loaded networks
could become a first line of protection for farmers under con-
stant exposure to pesticides and insecticides, for patients with
increased levels of xenobiotics in their blood or for those with
increased levels of microplastics in their system.
2.5. Examination of DNA-linked polymersome cluster
behavior in vivo
We finally examined the in vivo behavior of ssDNA–polymer-
some clusters (i.e. biodistribution, cluster stability) using the
zebrafish as a vertebrate screening model. Recently, it has
been shown that the zebrafish model is a straightforward tool
to study the systemic circulation and biodistribution of nano-
particles53 and the stability as well as enzymatic activity of arti-
ficial organelles.25 Therefore, we investigated mixtures of non-
complementary ssDNA–polymersomes encapsulating either
sulforhodamine B (SRB) or DY-633, as small molecule mimics,
and small and large polymersome clusters in transgenic kdrl:
EGFP zebrafish embryos, which express EGFP in their vascula-
ture endothelial cells. We injected all nanostructures intra-
venously into the blood circulation via the duct of Cuvier
(Fig. 5A and Fig. S6F, G† – characterization of clusters with
encapsulated SRB and DY-633 used in this in vivo study) and
analyzed the in vivo biodistribution at specific time points (0.5,
4, and 24 h) using CLSM (Fig. 5B). Interestingly, polymersome
mixtures as well as both small and large clusters showed a dis-
tinct binding pattern in the caudal vein region already after
30 min. After 24 hours all types of polymersomes remained
attached to the posterior caudal vein (PCV, Fig. 5B). This is an
interesting observation, since this region has been identified
as a model to assess the interaction of anionic nanoparticles
with scavenger receptors.54 Thus, both ssDNA–polymersomes
and the polymersome clusters were also recognized in vivo by
scavenger receptor expressing cells, confirming our in vitro
results.
To assess the in vivo stability of non-complementary ssDNA
polymersomes, small and large clusters, we performed a colo-
calization analysis of DY-633-P20-a and SRB-P20-b bearing
polymersome signals (Fig. 5C). In the case of non-complemen-
tary polymersome mixtures, both polymersome types showed a
strong binding to the same scavenger receptor expressing
regions, however with very low colocalization at all time points
(30 min: 0.28 ± 0.07; 4 h: 0.38 ± 0.05; 24 h: 0.38 ± 0.02, mean ±
s.e.m., n = 3). Thus, non-complementary polymersomes do not
assemble into clusters in blood circulation but bind to the
same target region. In sharp contrast, preformed polymersome
clusters exhibited a significantly higher colocalization of
DY-633-P20-a and SRB-P20-b signals at binding sites in vivo
(Fig. 5B and C). Manders’ M1 colocalization coefficients 24 h
post injection were 0.60 ± 0.07 and 0.65 ± 0.02 (mean ± s.e.m.,
n = 3) for small and large polymersome clusters, respectively.
Thus, the multiple factors that influence the disassembly of
DNA-linked nanomaterials such as serum proteins, enzymes
or shear force did not affect the polymersome clusters’ integ-
rity over time, confirming their stability even under in vivo
conditions.
3. Conclusions
In summary, we have developed soft DNA-linked assemblies
based on hierarchical organization of polymersomes that show
specific interactions with cell surfaces with exceptional stabi-
lity in vitro and in vivo thus strengthening our vision of devel-
oping them for biological applications. We demonstrated the
ability to control the size of DNA-linked polymersome clusters
by varying the ssDNA surface density. In vitro and in vivo be-
havior of the clusters are a direct result of the inherent deform-
ability and membrane fluidity of the polymersomes, where a
fraction of the ssDNAs can migrate to the protective bridging
regions, while the remaining unbound ssDNA fraction can
interact with scavenger receptors on the surface of epithelial
cells. Finally, we also demonstrated that a medically relevant
enzyme can be encapsulated within the DNA-polymersome
clusters and maintains its activity. Polymersome clusters have
the following advantages as compared to non-clustered or ss-
DNA-polymersomes: (i) they allow segregated nano-spaces
where different reactions can take place simultaneously, (ii)
support co-localization of polymersomes inducing an increase
in their overall functionality, (iii) tend to have better binding
to the cell surface and (iv) accumulate more on the cell
surface, thus supporting an improved functionality. In
addition, polymersome clusters are physiochemically stable in
the physiological environment and strongly attach to scavenger
receptor-expressing cells thus making them ideal candidates to
serve as nano-implants for sustainable and long-term thera-
pies. The unique in vitro and in vivo properties and robustness
propel this system towards the development of protective
detoxification networks. More importantly, the global enzyme
replacement treatment market is expected to grow 6.5% per
year and generate more than $13.7 billion each year by 2028.55
Our new approach and results could be extended to the
enzyme replacement market by replacing the encapsulated
enzyme to protect and deliver a broad context of therapeutic
enzymes to selective cells and complement cell functions in
blood circuits.
4. Materials and methods
See the ESI† for additional details. As a reporting standard has
been developed to strengthen the quality and reproducibility
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of published research in the field of bio-nano science,56 we
provide information of materials including synthesis and
characterization, size distribution, shape, dimensions, aggre-
gation, zeta potentials, density (in culture), enzyme loading
efficiency, labelling efficiency, stability in biological fluids, as
well as biological characterization including toxicity, 3D-
mapping of materials on cell surfaces for selective targeting
quantification, mechanism of selective targeting, material dis-
tribution in Zebra fish, and statistics for data analysis.
4.1. Materials
Hydroxylethoxypropyl terminated polydimethylsiloxane was
purchased from ABCR GmbH (AB 116675), Germany. The oli-
gonucleotides with DBCO modification on the 5′-end and the
ones with both DBCO modification on the 5′-end and ATTO
488/Cy5 modification on the 3′-end were purchased from IBA
GmbH, Germany. DBCO-OEG4-ATTO 488 was purchased from
Jena Bioscience, Germany. The fluorescent probes ATTO 488
and DY-633 were purchased from ATTO-TEC GmbH, Germany,
and Dyomics GmbH, Germany, respectively. CHCl3 in HPLC-
grade quality for GPC elution were obtained from Scharlab,
Spain. All other chemicals were purchased from Sigma-Aldrich
in the highest available grade and used as received if not
stated otherwise.
4.2. Block copolymers
PDMS62-PMOXA13 was synthesized according to the published
procedure.57 PDMS62-PMOXA13-OH:
1H NMR (400 MHz, δ,
CDCl3): 0 ppm (m, –Si(CH3)2), 0.54 ppm (m, –SiCH2), 0.88 ppm
(t, –CH3), 1.31 ppm (m, –CH2–CH2–), 1.62 ppm (m, –SiCH2–
CH2–CH2O–), 2.08–2.21 ppm (m, CH3–CvO), 3.40–3.60 ppm
(m, –CH2–O–CH2–CH2–N–CH2–CH2–), 3.75 ppm (t, –CH2OH).
For the synthesis of N3-functionalized polymer, PDMS65-
PMOXA32 (400 mg, 54.0 µmol) was dissolved in 5 mL anhy-
drous CHCl3, following the addition of 14-azido-3,6,9,12-tetra-
oxatetradecanoic acid solution (0.5 M in tert-butyl methyl
ether, 2.6 eq.), N,N′-dicyclohexylcarbodiimide (DCC, 2.6 eq.),
triethylamine (5.2 eq.) and 4-dimethylaminopyridine (0.2 eq.)
under Ar flow. The reaction flask was placed in an ice bath at
0 °C, warmed to room temperature gradually and reacted
further for 2 days. The crude azide-functionalized diblock
copolymers were purified by dialysis (MWCO 3.5 kDa) in H2O/
EtOH (4 : 6 V/V). 1H NMR (400 MHz, CDCl3): 0 ppm (m, –Si
(CH3)2), 0.54 ppm (m, –SiCH2), 0.88 ppm (t, –CH3), 1.31 ppm
(m, –CH2–CH2–), 1.62 ppm (m, –SiCH2–CH2–CH2O–),
2.08–2.21 ppm (m, CH3–CvO), 3.40–3.60 ppm (m, –CH2–O–
CH2–CH2–N–CH2–), 3.65 ppm (s, –O–CH2–CH2–O–CH2–CH2–O–
CH2–CH2–O–CH2–).
4.3. ssDNA–polymersomes
Polymersome formation. The block copolymers, PDMS62-
PMOXA13 and PDMS71-PMOXA25-OEG3-N3, were dissolved in
ethanol and chloroform, respectively, to yield stock solutions
with a concentration of 10 mg mL−1 and mixed in the respect-
ive ratio to prepare polymersomes with various amounts of
azide groups on the polymersome’ surface. PDMS62-PMOXA13
(400 µL × 10 mg mL−1, 4 mg, 5800 g mol−1 measured by GPC,
0.7 µmol) was mixed with 0.5 (2.3 µL × 10 mg mL−1, 0.023 mg,
6400 g mol−1 measured by GPC, 3.6 nmol), 1, 5, 10, 20 and
33 mol% of PDMS71-PMOXA25-OEG3-N3 in a 5 mL round-
bottom flask, followed by solvent removal on a rotary evapor-
ator (140 mbar, 40 °C, 75 rpm). The thin polymer film was
rehydrated by adding 1 mL PBS and stirred overnight at room
temperature. The yielded solution was extruded with an Avanti
mini-extruder (Avanti Polar Lipids, Alabama, USA) through a
polycarbonate (PC) membrane with a 200 nm diameter pore
size for 15 times to unify the size of polymersomes.
To visualize the polymersomes by CLSM, 0.2 mM ATTO 488,
0.2 mM DY-633 or 0.2 mM SRB was dissolved in 1 mL PBS and
used for the film rehydration instead of PBS to prepare the
polymersomes P20. Dye-encapsulated polymersomes were
extruded as mentioned above and purified from non-encapsu-
lated fluorescent probes by size exclusion chromatography
(SEC, Sepharose 4B column; 8 cm length). The fraction of indi-
vidual non-encapsulated fluorescent probes was collected and
the concentration was determined by measuring the maximal
UV-vis absorbance. The maximal molar extinction coefficient
(εmax) of ATTO 488 (λmax = 500 nm) DY-633 (λmax = 637 nm) and
SRB (λmax = 550 nm) is 9 × 10
4, 17 × 104 and 11 × 104 M−1
cm−1, respectively. The encapsulation efficiency of ATTO 488,
DY-633 and SRB for P20 is subsequently calculated as 10.4%,
24.7% and 18.7%, respectively (eqn (1)).
E ¼ N0  Nf
N0
ð1Þ
E is the encapsulation efficiency, N0 is the initial moles of the
dye used for encapsulation and Nf is the moles of the free dye
after encapsulation.
Coupling of DBCO-OEG4-ATTO 488 to polymersomes. 100 µL
of 4 mg mL−1 of polymersomes with different N3 content were
incubated with DBCO-OEG4-ATTO 488 (1.2 eq. per azide group)
in Eppendorf tubes (capacity 200 µL), at 37 °C and 300 rpm for
24 h. The unreacted DBCO-OEG4-ATTO 488 was removed by
SEC eluted by PBS (Sepharose 4B column; 8 cm length). The
volume of samples after purification was measured and the
concentration of purified DBCO-ATTO 488-labled polymer-
somes (weight of polymer in solution) was calculated.
Conjugation of ssDNA to polymersomes. 100 μL of 4 mg
mL−1 of polymersomes with different N3 content were incu-
bated with various amounts of 22 bp DBCO-ssDNAa or the
complementary DBCO-ssDNAb (1 eq. per azide group), at 37 °C
300 rpm for 2.5 days. The total volume of sample solution
used is always more than 100 µL to avoid drying the polymer-
somes due to water evaporation. The ssDNA–polymersomes
were purified by SEC and the concentration was calculated as
mentioned above. ssDNAa-488 and ssDNAb-Cy5 were conju-
gated to distinct polymersomes by the same procedure for the
quantification of ssDNAa and ssDNAb per polymersome.
Additionally, the conjugation of ssDNA to dye-encapsulated
polymersomes was performed by the same procedure for the
visualization in vitro and in vivo. Non-encapsulated free dyes
and non-linked free ssDNA was removed together by SEC. To
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prepare large clusters for in vitro and in vivo studies, the conju-
gation of ssDNA to dye-encapsulated P20 was slightly modi-
fied. The concentration of polymersomes and the corres-
ponding ssDNAa/b was doubled to increase the reaction
efficiency, thereby resulting higher number of ssDNA per
polymersomes.
4.4. DNA-linked polymersome clusters
Formation of polymersome clusters. In general, the polymer-
some clusters were prepared by incubating 0.1 mg mL−1 of
ssDNAa-polymersomes with 0.1 mg mL−1 of the corresponding
ssDNAb-polymersomes at 37 °C. Dye-encapsulated polymer-
somes were used for in vitro and in vivo studies. The apparent
DH of clusters was monitored by DLS as a function of time and
all of them except that of P33-ab reached to a plateau after 24 h
incubation at 37 °C. Therefore, the preparation of all polymer-
some clusters except large clusters for in vitro and in vivo
studies were performed at 37 °C at least for one day to assure
that no further increase of the apparent DH would occur. P-a
and the corresponding P-b were prepared from the same parent
polymersomes bearing azide groups to minimize the devi-
ation of polymersomes’ concentration from different batches.
Additionally, as polymersomes bearing larger amount of ssDNA
assembled rapidly, they were incubated at RT for 6 h and kept
in the fridge before the utilization for in vitro and in vivo study.
DNase I digestion. 0.2 mg mL−1 of P1-ab, P5-ab, P10-ab and
P20-ab polymersome clusters were diluted in PBS to reach a
concentration of 0.025 mg mL−1, 0.05 mg mL−1 and 0.1 mg
mL−1. The diluted polymersome cluster solutions were further
treated with various concentrations of DNase I (0.1 µg mL−1,
1 µg mL−1 and 10 µg mL−1, final volume 400 μL) in presence
of 5 mM of the cofactor MgCl2. All samples were incubated at
37 °C for 1 day followed by DLS measurements for the size
analysis. For the control experiment, 0.1 mg mL−1 of P20-a and
P20-b were pre-treated with 1 µg mL−1 of DNase I at 37 °C for
24 h, respectively, and mixed at 37 °C for another 24 h, follow-
ing up with characterization of TEM. In order to understand
the influence of DNA length on the nuclease resistance of poly-
mersome clusters, polymersomes were linked with comp-
lementary 11 bp ssDNA, respectively, and purified as afore-
mentioned. The sequences of 11 bp ssDNA are 5′-DBCO-CCT
CGC TCT GC-ATTO 488-3′ and 5′-DBCO-GCA GAG CGA
GG-ATTO 643N-3′, respectively. The DNA density on the poly-
mersome’ membrane was carefully controlled in order to
obtain the polymersome clusters with a size similar to P20-ab.
0.025 mg mL−1, 0.05 mg mL−1 and 0.1 mg mL−1 of polymer-
some clusters linked by 11 bp DNAs was treated with DNase I
at 0.1 µg mL−1, 1 µg mL−1 and 10 µg mL−1 at 37 °C for 1 day,
respectively. The samples were incubated followed by charac-
terization as aforementioned for polymersome clusters.
Stability of polymersome clusters in cell medium with
serum. 0.025 mg mL−1 of P20-ab polymersome clusters were
incubated in cell medium with serum. The change of the size
at 37 °C was continually recorded by DLS.
FRET analysis. P20 was conjugated with ssDNAa-Cy3 or
ssDNAb-Cy5, purified as mentioned above, and used for the
FRET analysis. Firstly, 400 μL of 0.2 mg mL−1 of P20-b-Cy5 was
added with excess amount of ssDNAa-Cy3 and the increase in
florescence emission at 660 nm (λex = 530 nm) caused by the
hybridization of free ssDNAa-Cy3 to ssDNAb-Cy5 on the poly-
mersome’s surface due to FRET was recorded by fluorimeter.
Secondly, 200 μL of 0.4 mg mL−1 of P20-b-Cy5 was added with
200 μL of 0.4 mg mL−1 of P20-a-Cy3. The increase in flor-
escence emission at 660 nm was recorded as aforementioned.
The fluorescence intensity of ssDNAa-Cy3 and P20-a-Cy3 as a
function of time at 660 nm was recorded additionally and sub-
tracted from data to avoid any contribution to fluorescence
intensity when calculating FRET efficiency. The percentage of
hybridized ssDNA when forming clusters was calculated by
dividing the increase of fluorescence intensity of P20-b-
Cy5 hybridizing with P20-a-Cy3 with the value when P20-b-
Cy5 hybridized with excess amount of ssDNAa-Cy3. The size
change when P20-b-Cy5 mixing with P20-a-Cy3 was monitored
by DLS, which proved the cluster formation during the FRET
analysis.
4.5. In vitro studies of the behavior of the DNA-linked
polymersome clusters
Cell culture. HEK293T (embryonic kidney, human; ATCC,
CRL-3216), HeLa (epitheloid cervix carcinoma, human; ATCC,
CCL-2) and U87-MG (glioblastoma cells obtained from the
University of Basel Hospital) were cultured in Dulbecco’s
Modified Eagle Medium (DMEM, Gibco Life Sciences) with
GlutaMAX™-I and supplemented with 10% FCS (BioConcept),
100 units per mL penicillin and 100 µg mL−1 streptomycin
(Sigma Aldrich). Cells were maintained at 37 °C and 5% CO2.
Cell viability assay. CellTiter 96® AQueous One Solution Cell
Proliferation Assay (MTS, Invitrogen) was used in accordance
with the provided protocol to determine cell viability. HeLa
cells were seeded in a 96 well plate (3000 cells per well) and
cultured for 24 h at 37 °C and 5% CO2. After 24 h 40 µL of
0.2 mg mL−1 unfunctionalized polymersomes, polymersomes
containing 20% azide, ssDNA-a polymersomes, ssDNA-b poly-
mersomes, or polymersome clusters were added to the cells to
reach a final volume of 200 µL and incubated further for 24 h.
The MTS reagent (20 µL) was added to each well and absor-
bance at 490 nm was measured after 2 h using a Spectramax
plate reader. Background absorbance was subtracted from
each well and data was normalized to control cells.
Experiments were done in quadruplicate (n = 4) and data was
plotted using GraphPad Prism.
Cell imaging experiments. HEK293T, HeLa and U87 MG
cells were seeded (3 × 104 cells in 300 µL cell culture medium
per well) in 8-well ibidi collagen IV coated plates. After 24 h
the cell culture medium was removed and replaced with
280 µL fresh culture medium (DMEM-GlutaMAX™-I with 10%
FCS, 1% penicillin/streptomycin). Next, we added unmodified
polymersomes, ssDNAa polymersomes (DY-633-P20a) or poly-
mersome clusters to the cells (20 µL, 0.2 mg mL−1) and incu-
bated further for 24 h. Before live cell imaging, we washed the
cells 4× with Opti-MEM (Gibco Life Sciences) and stained the
cell membrane with CellMask™ orange plasma stain accord-
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ing to provided protocol (Invitrogen). After staining, cells were
further washed 3× and imaged by CLSM.
Flow cytometry. HEK293T, HeLa and U87 MG cells were
seeded (1.2 × 105 cells per well, 360 µL final volume) in 24-well
plates in cell culture medium. After 24 h, 40 µL of 0.2 mg
mL−1 unfunctionalized polymersomes, ssDNA-a polymer-
somes, small clusters or large clusters were added to the cells
and further incubated for 24 h. Cells were then washed with
PBS and trypsinized with 150 µL trypsin-EDTA (Sigma Aldrich).
Cells were resuspended in cell media, transferred to 1.5 mL
microcentrifuge tubes and centrifuged for 5 min at 1 rcf. The
supernatant was removed and the cell pellet resuspended in
500 µL cold PBS and put on ice until flow cytometry analysis.
Flow cytometry analysis was performed using a BD FACSCanto
II flow cytometer (BD Bioscience, USA). Doublets were
excluded using FSC and SSC detectors, single cells were
excited at 488 nm or 633 nm and the emission was detected in
FL1 (530/30; Atto488 Channel) and FL3 (630/30 DY-633
Channel). A total of 10 000 single cells for each sample were
analyzed, and data processed using Flow Jo VX software
(TreeStar, Ashland, OR).
Inhibition of cluster binding. HEK293T cells were seeded in
8-well collagen IV coated plates (ibidi) as described above.
Cells were then treated with either polyinosinic acid or
Fucoidan (10 µg ml−1 or 50 µg mL−1 final concentrations).
After 1 h, ssDNA–polymersomes, small or large clusters (20 µL,
0.2 mg mL−1) were added to the cells and incubated further
for 24 h. Cells were then washed, stained and imaged using
the same procedure as described above to allow for
comparison.
Formation of DNA-polymersome clusters with encapsulated
laccase. PDMS62-PMOXA13 (400 µL × 10 mg mL
−1) was mixed
with 20 mol% of PDMS71-PMOXA25-OEG3-N3 in a 5 mL round-
bottom flask, followed by solvent removal. The polymer film
was rehydrated by adding 950 μL PBS containing 1 mg mL−1 of
laccase from t. versicolor (EC 1.10.3.2) and 50 μL of previously
expressed, purified and dialyzed OmpF (60 μg mL−1 final con-
centration), as previously described44 and stirred overnight at
room temperature. As a control, polymersomes with laccase
and no OmpF were prepared. The resulting polymersomes
were then extruded through a 200 nm diameter pore mem-
brane size 15 times as described above. Free laccase was
removed using a Sepharose 4B size exclusion column (30 cm
length). The non-encapsulated laccase fraction was recovered
from the control polymersomes with no OmpF during purifi-
cation by size exclusion chromatography and its concentration
quantified at 280 nm with Nanodrop 2000 (Thermo Fisher
Scientific, USA), using the MW and ε calculated from the
amino acid sequence on ExPASy. By subtracting the total
amount present in the non-encapsulated fraction from the
added amount of laccase, the final enzyme concentration in
the sample was calculated to be 421 μg mL−1 for naked poly-
mersomes and 0.42 μg mL−1 after ssDNA conjugation.
Enzymatic activity assay. The enzymatic assays were per-
formed by following the production of resorufin (Ex. λ = 529
Em. λ = 600 nm) from Amplex Ultra Red thanks to the action
of the laccase catalytic polymersomes (Lac-Polymersomes).58
Briefly, in a black flat-bottomed 96-well plate (Thermo Fisher
Scientific, USA), either free laccase, naked Lac-Polymersomes
or DNA-lined Lac-Polymersome clusters were added to a final
concentration of 6 μg mL−1, with AR (final concentration
1 μM) in either PBS or male human serum to a final volume of
0.2 mL. The fluorescence was measured after 5 minutes, the
baseline due to AR autoxidation was subtracted and the reac-
tion efficiency was expressed as
IntensitySample
Intensity Free enzyme
% with
intensity measured as arbitrary fluorescent units.
4.6. In vivo studies of the behavior of the DNA-linked
polymersome clusters
Zebrafish injection. Zebrafish husbandry and embryo main-
tenance were performed at standard conditions and in accord-
ance with Swiss animal welfare regulations. Eggs were col-
lected and kept in zebrafish culture media containing 1-phenyl
2-thiourea (PTU) in order to suppress pigment cell formation
as already described elsewhere.59 Small clusters formed by
DY-633-P20-a and SRB-P20-b, large clusters formed by DY-633-
P20-a and SRB-P20-b, and non-clustered sample containing
DY-633-P20-b and SRB-P20-b were injected into zebrafish
blood circulation (3 nL, 0.2 mg mL−1) via the Duct of Cuvier at
2 days post fertilization (dpf).60 Injected live zebrafish embryos
were casted into 0.3% agarose (w/v) containing 0.01% tricaine
(w/v) as anesthetic. Injections were performed using a micro-
manipulator (Wagner Instrumentenbau DG, Schöffengrund,
Germany), a Pico Pump PV830 (WPI, Sarasota, Florida), and a
Leica S8APO microscope (Leica, Wetzlar, Germany). Confocal
micrographs were taken using an Olympus FV-1000 inverted
confocal laser scanning microscope equipped with a 10×
UPlanSApo (NA 0.4) and 20× UPlanSApo (NA 0.75) objective.
Colocalization analysis based on Manders’ M1 colocalization
coefficient was performed using the Fiji ImageJ JaCoP plugin.
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